Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. (Q50501810)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 October 2012

Language	Label	Description	Also known as
English	Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.	scientific article published on 13 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Cibele M. Prado

4

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

object named as

Carla S Ceron

2

0 references

author name string

Elen Rizzi

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Danielle A Guimaraes

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Marcos A Rossi

5

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Raquel F Gerlach

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Jose E Tanus-Santos

7

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

publication date

13 October 2012

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

94

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

1-9

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

ECM remodeling in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

The regulation of matrix metalloproteinases and their inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Rat models of hypertension, cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Angiotensin II induces MMP-2 in a p47phox-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Tissue inhibitor of metalloproteinases (TIMPs) in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Controversies in ventricular remodelling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

TGF-beta1 and angiotensin networking in cardiac remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during acute pulmonary thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix metalloproteinases: regulation and dysregulation in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Oxidative stress and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Activation and modulation of 72kDa matrix metalloproteinase-2 by peroxynitrite and glutathione

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.10.010

7 January 2021

Identifiers

10.1016/J.YEXMP.2012.10.010

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/23073243

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50501810&oldid=1370696688"